Securities Fraud Complaint Filed Against Pulse Biosciences


A securities fraud lawsuit has been filed against Pulse Biosciences, Inc.  (NASDAQ: PLSE) for potential securities violations on behalf of shareholders who purchased shares anytime during the period from January 12, 2021 through February 7, 2022.  The release of potentially misrepresentative and misleading information, as well as failure to disclose material adverse facts to the […]

The Uniform Securities Act: Securities Attorney Primer


Each U.S. state has its own security laws that are commonly referred to as “blue sky laws.”  The Uniform Securities Act is a set of model laws pertaining to securities law and issues that was created as a starting point for the drafting of uniform state-level securities regulation when promulgating securities law.  The Uniform Securities […]